Formulated for severe acne and hirsutism to manage hormonal imbalances and support skin health.
Mechanism of Action
Cyproterone acetate blocks androgen receptors and inhibits gonadotropin secretion. Ethinyl estradiol stabilizes the menstrual cycle and reduces sebum production by increasing sex hormone-binding globulin levels.
Route of Administration
Oral
Onset Time
1–3 months
Duration
24 hours
Contraindications
History of thromboembolic disease, Breast cancer, Heavy smoking over age 35, Severe liver disease
Severe Adverse Events
Deep vein thrombosis, Pulmonary embolism, Hepatotoxicity — requires immediate medical attention
Common Side Effects
Nausea, Headache, Breast tenderness
Uncommon Side Effects
Mood changes, Weight changes, Spotting
Drug Interactions
Alcohol, Tobacco, Rifampin, St. John's Wort, Phenytoin
Pregnancy Safety Warnings
FDA Category X: Strictly contraindicated in pregnancy. Breastfeeding: Excreted in milk; not recommended.
Information related to Cyproterone Acetate with Ethinylestradiol is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
